" class="no-js "lang="en-US"> Holmusk Signs Agreements with UTHealth and The Harris Center - Medtech Alert
Thursday, May 23, 2024

Holmusk Signs Agreements with UTHealth and The Harris Center

Holmusk, a leading global data science and health technology company building the world’s largest Real-World Evidence (RWE) platform for behavioral health, has signed data license agreements with The University of Texas Health Science Center at Houston (UTHealth) and The Harris Center for Mental Health and IDD (The Harris Center) in Harris County, Texas.

The UTHealth Harris County Psychiatric Center (HCPC) is the largest inpatient psychiatric care provider in Houston. The Harris Center is a large publicly funded outpatient behavioral health safety net provider serving the third largest county in the country. Together, they provide care to over 80,000 patients annually, and have a strong collaborative relationship to offer comprehensive, coordinated care to patients referred between the two centers.

The agreements give Holmusk access to deidentified health care data, which will be used to develop AI-powered analytic models that drive improved clinical outcomes. Holmusk will leverage its expertise in behavioral health data analytics to overcome the challenge of creating longitudinal patient records across the two facilities, which store data in multiple legacy Electronic Health Record (EHR) systems. Holmusk will leverage its proprietary Natural Language Processing (NLP) models and AI capabilities to create clinically relevant analytic tools, such as identifying patients at higher risk of 30-day hospital readmission. This dataset will fuel NeuroBlu, Holmusk’s RWE platform for behavioral health. NeuroBlu is currently the leading source of behavioral health Real-World Data, with over 20+ years of longitudinal clinical data with structured disease severity scores and NLP-derived symptoms, external stressors, and side effects.

“The Harris Center has worked closely with UTHealth HCPC for a number of years to provide the best continuum of care for our patients in and around Harris County,” stated Wayne Young, Chief Executive Officer of The Harris Center. “With thousands of patient referrals from UTHealth HCPC to The Harris Center every year, it’s imperative that we have a robust data set to not only make informed health-related decisions, but to continue to create innovative solutions for those with severe behavioral health conditions.”

“A fundamental premise at Holmusk is that real-world data can unlock our understanding of patient needs. We see significant potential to understand optimal care delivery and improve outcomes by using data efficiently to address the unmet need in mental health. We are excited to work with UTHealth HCPC and The Harris Center to bring together patient records and work with them to improve care delivery for future patients,” said Holmusk’s Chief Medical Officer, Scott Kollins.

“We are excited to partner with these premier behavioral health providers to integrate data sources in a way that, prior to now, has been impossible,” said Joydeep Sarkar, Holmusk Chief Data Analytics Officer. “Our data science capabilities will greatly facilitate the interoperability of patient health data across the care continuum to optimize outcomes.”

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more